BioStem Technologies, Inc. Awarded Q Code for VENDAJE® Product Line From CMS.
July 23, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., July 23, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies, Inc. Announces Launch of National Sales Force Expansion
April 15, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., April 15, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies, Inc. Reports Financial Results for Fourth Quarter and Fiscal Year 2020
April 05, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., April 05, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading pre-clinical-stage biotechnology company focused on...
BioStem Technologies, Inc. Receives TRIP (TRG Rapid Inquiry Program) Response for VENDAJE™
March 25, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., March 25, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies Engages D. Brooks & Associates for 2020 and 2019 Audit
March 15, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., March 15, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading pre-clinical-stage biotechnology company focused on...
BioStem Technologies, Announces Filing of 2020 Quarterly Reports
December 24, 2020 14:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl, Dec. 24, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue...
BioStem Technologies, Inc. Announces Launch of AEON™
October 27, 2020 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., Oct. 27, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue...
BioStem Technologies, in Partnership with Veterans Medical Distributors Inc., Announces Five-Year Federal Supply Schedule Contract with the Department of Veterans Affairs
September 01, 2020 17:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., Sept. 01, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue...
BioStem Life Sciences Signs Manufacturing Agreement for Amniotic Membrane Allograft Platform
August 11, 2020 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Aug. 11, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based...
BioStem Technologies, Inc. Announces Update Regarding Timeline to Become Current Reporting with OTC Markets During Q4 2020
July 22, 2020 17:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, July 22, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based...